Nifty
Sensex
:
:
22212.70
73142.80
-4.75 (-0.02%)
-15.44 (-0.02%)

Pharmaceuticals & Drugs - API

Rating :
70/99

BSE: 524558 | NSE: NEULANDLAB

7001.80
23-Feb-2024
  • Open
  • High
  • Low
  • Previous Close
  •  7210.00
  •  7235.00
  •  6871.60
  •  7199.35
  • Volume
  • Traded Value (lacs)
  • 52 Week High
  • 52 Week Low
  •  41471
  •  2899.24
  •  7318.30
  •  1561.10

Stock Summary

  • Market Cap(Crs)
  • Stock P:E
  • Face Value
  • 8,984.96
  • 28.34
  • 10
  • Enterprise Value(Crs)
  • Dividend Yield
  • Price:Book Value
  • 8,943.91
  • 0.14%
  • 7.41

Shareholding Pattern

  • Promoter
  • Corporate
  • Public
  • 32.80%
  • 6.62%
  • 29.52%
  • FII
  • DII
  • Others
  • 22.69%
  • 2.23%
  • 6.14%

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 9.85
  • 12.30
  • 8.33

EBITDA CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 14.43
  • 36.03
  • 13.11

PAT CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 19.82
  • 58.32
  • 26.58

P:E (Median)

  • 8 Years
  • 5 Years
  • 3 Years
  • 31.37
  • 29.00
  • 26.21

P:BV (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • 3.09
  • 2.52
  • 3.20

EV:EBITDA (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • 14.01
  • 13.82
  • 14.45

Quarterly Results

Consolidated Figures in Rs. Crores /

Standalone
Description
Dec 23
Dec 22
Var%
Sep 23
Sep 22
Var%
Jun 23
Jun 22
Var%
Mar 23
Mar 22
Var%
Net Sales
392.83
269.25
45.90%
417.75
293.71
42.23%
362.99
221.17
64.12%
407.07
255.87
59.09%
Expenses
271.56
215.17
26.21%
280.26
224.41
24.89%
266.07
192.57
38.17%
287.21
217.00
32.35%
EBITDA
121.27
54.08
124.24%
137.49
69.30
98.40%
96.92
28.60
238.88%
119.86
38.87
208.36%
EBIDTM
30.87%
20.09%
32.91%
23.59%
26.70%
12.93%
29.44%
15.19%
Other Income
2.10
0.93
125.81%
3.05
0.24
1,170.83%
2.04
0.51
300.00%
8.06
0.63
1,179.37%
Interest
3.74
2.75
36.00%
4.43
3.17
39.75%
2.21
2.86
-22.73%
4.29
2.77
54.87%
Depreciation
15.14
13.34
13.49%
14.51
13.17
10.17%
13.59
12.80
6.17%
13.47
12.45
8.19%
PBT
104.48
38.94
168.31%
121.59
53.19
128.60%
83.16
13.46
517.83%
110.16
24.28
353.71%
Tax
23.09
8.39
175.21%
32.35
14.73
119.62%
21.28
3.49
509.74%
25.62
2.50
924.80%
PAT
81.39
30.55
166.42%
89.25
38.46
132.06%
61.88
9.97
520.66%
84.54
21.78
288.15%
PATM
20.72%
11.35%
21.36%
13.10%
17.05%
4.51%
20.77%
8.51%
EPS
63.09
23.68
166.43%
69.18
29.81
132.07%
47.96
7.73
520.44%
65.53
16.88
288.21%

Annual Results

Consolidated Figures in Rs. Crores /

Standalone
Description
TTM
Mar 23
Mar 22
Mar 21
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Mar 14
Net Sales
1,580.64
1,191.20
951.08
936.91
762.71
666.83
527.41
578.89
509.97
469.15
465.69
Net Sales Growth
51.98%
25.25%
1.51%
22.84%
14.38%
26.43%
-8.89%
13.51%
8.70%
0.74%
 
Cost Of Goods Sold
613.00
478.23
422.14
438.42
380.20
366.24
238.37
262.90
253.46
243.99
246.53
Gross Profit
967.64
712.97
528.94
498.50
382.51
300.59
289.04
315.99
256.52
225.16
219.16
GP Margin
61.22%
59.85%
55.61%
53.21%
50.15%
45.08%
54.80%
54.59%
50.30%
47.99%
47.06%
Total Expenditure
1,105.10
919.36
808.46
790.09
660.82
608.46
476.98
472.55
429.52
402.53
395.08
Power & Fuel Cost
-
48.62
42.21
39.21
32.75
26.81
25.95
25.78
22.24
22.53
18.31
% Of Sales
-
4.08%
4.44%
4.19%
4.29%
4.02%
4.92%
4.45%
4.36%
4.80%
3.93%
Employee Cost
-
201.79
182.47
149.74
123.56
110.46
102.99
92.74
65.38
51.81
41.74
% Of Sales
-
16.94%
19.19%
15.98%
16.20%
16.56%
19.53%
16.02%
12.82%
11.04%
8.96%
Manufacturing Exp.
-
86.94
89.16
77.10
64.84
50.10
55.54
44.90
39.31
43.56
40.98
% Of Sales
-
7.30%
9.37%
8.23%
8.50%
7.51%
10.53%
7.76%
7.71%
9.28%
8.80%
General & Admin Exp.
-
51.22
35.80
38.93
27.75
27.49
33.32
28.30
29.72
23.59
15.95
% Of Sales
-
4.30%
3.76%
4.16%
3.64%
4.12%
6.32%
4.89%
5.83%
5.03%
3.43%
Selling & Distn. Exp.
-
29.58
27.40
34.63
18.30
18.28
14.04
11.16
17.52
14.54
26.57
% Of Sales
-
2.48%
2.88%
3.70%
2.40%
2.74%
2.66%
1.93%
3.44%
3.10%
5.71%
Miscellaneous Exp.
-
22.99
9.28
12.08
13.42
9.08
6.77
6.78
1.89
2.52
26.57
% Of Sales
-
1.93%
0.98%
1.29%
1.76%
1.36%
1.28%
1.17%
0.37%
0.54%
1.07%
EBITDA
475.54
271.84
142.62
146.82
101.89
58.37
50.43
106.34
80.45
66.62
70.61
EBITDA Margin
30.09%
22.82%
15.00%
15.67%
13.36%
8.75%
9.56%
18.37%
15.78%
14.20%
15.16%
Other Income
15.25
9.75
2.08
16.10
3.89
3.49
4.53
1.17
1.78
0.78
3.44
Interest
14.67
13.07
13.50
17.90
21.57
15.66
18.93
21.09
24.48
27.36
24.56
Depreciation
56.71
52.78
49.04
39.68
31.28
25.86
22.10
19.23
15.74
15.32
14.94
PBT
419.39
215.75
82.16
105.33
52.92
20.34
13.93
67.19
42.00
24.72
34.55
Tax
102.34
52.23
18.34
24.70
36.71
3.90
1.87
20.32
14.92
8.79
7.80
Tax Rate
24.40%
24.21%
22.32%
23.45%
69.37%
19.17%
13.42%
30.24%
35.52%
35.56%
22.58%
PAT
317.06
163.52
63.82
80.63
16.21
16.44
12.06
46.86
27.33
15.94
26.80
PAT before Minority Interest
317.06
163.52
63.82
80.63
16.21
16.44
12.06
46.86
27.08
15.93
26.75
Minority Interest
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.25
0.01
0.05
PAT Margin
20.06%
13.73%
6.71%
8.61%
2.13%
2.47%
2.29%
8.09%
5.36%
3.40%
5.75%
PAT Growth
214.67%
156.22%
-20.85%
397.41%
-1.40%
36.32%
-74.26%
71.46%
71.46%
-40.52%
 
EPS
247.70
127.75
49.86
62.99
12.66
12.84
9.42
36.61
21.35
12.45
20.94

Results Balance Sheet

Consolidated Figures in Rs. Crores /

Standalone
Description
Mar 23
Mar 22
Mar 21
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Mar 14
Shareholder's Funds
994.10
840.50
786.46
709.96
699.31
558.04
545.62
186.63
161.38
123.99
Share Capital
12.90
12.90
12.90
12.90
12.90
8.95
8.95
8.95
8.95
7.73
Total Reserves
981.20
827.60
773.56
697.06
686.41
238.24
225.81
177.68
152.42
116.26
Non-Current Liabilities
146.71
179.83
169.82
163.39
104.06
146.43
54.37
69.42
54.76
52.33
Secured Loans
74.25
104.25
88.13
77.37
60.72
103.49
29.81
33.40
21.22
8.87
Unsecured Loans
0.00
0.00
0.00
0.00
0.00
0.00
0.00
12.00
12.00
25.00
Long Term Provisions
10.29
11.91
9.44
12.49
11.91
9.87
9.28
6.85
6.38
5.14
Current Liabilities
438.96
363.16
368.51
357.63
326.98
366.93
285.60
268.00
295.14
306.90
Trade Payables
171.01
117.38
152.13
115.56
119.68
124.29
85.92
83.86
111.81
93.94
Other Current Liabilities
244.87
152.35
158.75
71.63
57.45
41.83
47.18
55.02
31.28
63.74
Short Term Borrowings
11.16
92.21
56.98
168.17
149.06
199.20
151.08
123.63
145.80
139.62
Short Term Provisions
11.93
1.21
0.64
2.27
0.80
1.59
1.41
5.50
6.25
9.61
Total Liabilities
1,579.77
1,383.49
1,324.79
1,230.98
1,130.35
1,071.40
885.59
524.05
511.53
483.48
Net Block
738.19
747.70
696.94
622.76
511.69
445.01
435.74
138.77
123.07
130.85
Gross Block
953.26
913.27
826.48
714.33
575.44
483.45
454.74
291.78
263.65
258.54
Accumulated Depreciation
215.07
165.57
129.54
91.57
63.75
38.44
19.00
153.00
140.58
127.69
Non Current Assets
818.87
802.70
775.20
715.79
676.88
624.20
510.54
209.87
195.76
195.93
Capital Work in Progress
40.57
20.46
17.25
23.75
104.47
126.09
19.60
40.48
41.47
34.56
Non Current Investment
0.52
0.50
19.35
30.17
30.21
30.21
30.20
7.39
7.39
7.36
Long Term Loans & Adv.
20.24
14.38
41.67
35.81
30.51
22.66
24.79
22.73
23.83
23.15
Other Non Current Assets
0.00
0.00
0.00
3.30
0.00
0.22
0.22
0.50
0.00
0.00
Current Assets
760.89
580.79
549.59
515.19
453.47
447.19
375.04
314.19
315.77
287.55
Current Investments
0.00
3.38
6.46
7.50
7.50
7.50
7.50
0.00
0.00
0.00
Inventories
279.23
265.21
247.61
219.55
192.65
175.09
135.11
126.66
113.40
93.42
Sundry Debtors
361.77
234.33
217.73
189.89
164.02
193.92
181.11
119.11
128.85
118.59
Cash & Bank
59.10
20.36
19.40
46.98
37.84
17.26
12.49
9.71
6.98
7.07
Other Current Assets
60.79
11.52
8.84
17.47
51.46
53.43
38.83
58.70
66.53
68.47
Short Term Loans & Adv.
47.09
46.00
49.55
33.80
31.77
37.15
25.30
46.68
45.23
43.01
Net Current Assets
321.94
217.64
181.08
157.55
126.49
80.27
89.45
46.18
20.63
-19.35
Total Assets
1,579.76
1,383.49
1,324.79
1,230.98
1,130.35
1,071.39
885.58
524.06
511.53
483.48

Cash Flow

Consolidated Figures in Rs. Crores /

Standalone
Description
Mar 23
Mar 22
Mar 21
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Mar 14
Cash From Operating Activity
237.21
60.39
189.36
57.34
69.91
11.27
38.68
44.83
13.17
48.77
PBT
215.75
82.16
105.33
52.92
20.34
13.93
67.19
42.00
24.72
34.55
Adjustment
76.05
66.30
40.08
58.28
39.11
40.43
43.96
33.73
36.34
34.37
Changes in Working Capital
-10.96
-67.58
49.22
-49.17
15.47
-40.02
-55.94
-19.17
-38.76
-16.82
Cash after chg. in Working capital
280.84
80.88
194.63
62.03
74.91
14.35
55.20
56.56
22.30
52.11
Interest Paid
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Tax Paid
-43.63
-20.49
-5.27
-4.68
-5.01
-3.08
-16.52
-11.73
-9.13
-3.34
Other Direct Exp. Paid
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Extra & Other Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Cash From Investing Activity
-61.50
-95.52
-84.42
-48.68
-77.23
-116.29
-42.11
-19.86
-14.13
-9.84
Net Fixed Assets
-60.11
-90.00
-105.64
-58.17
-70.35
-135.20
-142.08
-27.14
-12.02
-7.02
Net Investments
3.36
21.92
11.87
0.04
0.00
-0.01
-30.31
0.12
-0.03
0.00
Others
-4.75
-27.44
9.35
9.45
-6.88
18.92
130.28
7.16
-2.08
-2.82
Cash from Financing Activity
-135.80
37.72
-113.66
-5.48
11.98
104.85
-0.09
-23.62
1.15
-38.96
Net Cash Inflow / Outflow
39.92
2.59
-8.72
3.18
4.66
-0.17
-3.51
1.35
0.19
-0.03
Opening Cash & Equivalents
5.09
2.44
11.20
7.94
3.29
3.44
6.97
0.81
0.62
0.65
Closing Cash & Equivalent
45.42
5.09
2.44
11.20
7.94
3.29
3.44
2.16
0.81
0.62

Financial Ratios

Consolidated /

Standalone
Description
Mar 23
Mar 22
Mar 21
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Mar 14
Book Value (Rs.)
774.12
654.40
612.28
552.65
544.35
277.21
263.23
209.07
180.72
153.48
ROA
11.04%
4.71%
6.31%
1.37%
1.49%
1.23%
6.65%
5.23%
3.20%
5.89%
ROE
17.84%
7.85%
10.79%
2.30%
3.48%
5.02%
22.34%
15.64%
11.24%
24.14%
ROCE
20.94%
9.44%
12.81%
7.85%
3.99%
4.07%
15.98%
18.57%
15.75%
18.99%
Fixed Asset Turnover
1.28
1.09
1.22
1.18
1.26
1.13
1.57
1.86
1.82
1.87
Receivable days
91.33
86.74
79.40
84.68
97.96
129.34
93.22
87.45
94.81
83.45
Inventory Days
83.41
98.40
91.00
98.63
100.64
106.98
81.29
84.66
79.24
71.34
Payable days
110.05
116.52
111.44
65.43
75.72
82.06
67.03
85.01
92.70
82.14
Cash Conversion Cycle
64.68
68.63
58.96
117.88
122.89
154.27
107.48
87.10
81.35
72.66
Total Debt/Equity
0.12
0.28
0.22
0.37
0.33
1.30
0.82
0.98
1.17
1.55
Interest Cover
17.51
7.09
6.89
3.45
2.30
1.74
4.19
2.72
1.90
2.41

Source: www.accordfintech.com | DISCLAIMER: Information is provided " as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.